Engineering Confidence in ADC Development: Let’s Connect in San Diego

san diego conference

Table of Contents

Share

san diego conference

Engineering Confidence in ADC Development: Let’s Connect in San Diego

DES Pharma (Dynamic Engineering Solutions) will be attending the 17th World ADC San Diego, taking place October 12-15, 2026 at the Town and Country Resort in San Diego, California. Hosted by Hanson Wade, World ADC San Diego is the longest-standing and largest dedicated antibody-drug conjugate congress in the industry, and our team will be on site for the full four days.

  • Event: 17th World ADC San Diego
  • Dates: October 12-15, 2026
  • Venue: Town and Country Resort, 500 Hotel Circle North, San Diego, CA 92108
  • Format: Pre-conference seminar day, two main conference days, post-conference workshop day
  • DES Pharma: Attending; meeting slots available across all four days

What Makes World ADC San Diego Different

Antibody-drug conjugates have moved from a niche modality to one of the most competitive areas in oncology, and the science has outpaced the infrastructure that supports it. World ADC San Diego is where that gap gets discussed openly, across the full development chain rather than in isolated silos.

According to the organizers, the 2026 program brings together more than 1,300 attendees from over 400 companies, with roughly two thirds of the audience at director level or above, and a speaker faculty of more than 170. Content runs across seven parallel tracks:

  • Discovery Chemistry: novel payload mechanisms of action and combination strategies
  • Discovery Biology: antibody targeting and engineering for improved therapeutic properties
  • Preclinical: reducing translational mismatch across traditional and novel conjugates
  • Translational Medicine: patient selection, dosing, and early trial design
  • Clinical Lessons: achieving differentiation in a crowded clinical landscape
  • Process & Analytical Development: quality characterization and process control for complex conjugates
  • Manufacturing & Supply Chain: internal and outsourced CMC strategy for cost-effective ADCs at scale

A separate Introduction to ADCs day runs ahead of the main program for teams newer to the modality, and the 2026 agenda adds a facilitated icebreaker networking session in the exhibition hall, grouping attendees by area of ADC expertise. Full session details are available in the event guide.

Why You Should Meet with DES Pharma at World ADC San Diego:

An ADC is not one product; it is three converging supply chains held together by a conjugation step. You have a monoclonal antibody with biologics-grade requirements, a linker-payload with high-potency small molecule requirements, and a conjugated drug substance that inherits the regulatory burden of both. Add a fill-finish site and, frequently, a lyophilization step, and a single batch may touch four organizations on two continents before it reaches a patient.

In our experience, most ADC program delays are not chemistry failures. They are coordination failures: a comparability protocol written without input from the conjugation site, a payload sole-source that nobody stress-tested, an analytical method that transfers cleanly on paper but not in the receiving lab. Those problems are cheap to prevent and expensive to fix after the fact.

DES Pharma works across all three chains. Whether you are preparing an IND, scaling a conjugation process out of the pilot plant, tightening drug-to-antibody ratio control, or rebuilding a supply base around a second payload source, our team brings hands-on engineering and CMC experience to the specific bottleneck in front of you.

Topics We Will Be Discussing in San Diego

  • Conjugation process development and DAR control: reaction design, in-process controls, and the process parameters that actually move drug-to-antibody ratio distribution and unconjugated species.
  • Analytical characterization and comparability: orthogonal method strategy across HIC, SEC, reversed-phase, and LC-MS; free payload and residual solvent control; building a comparability package that survives a site change.
  • High-potency containment and occupational safety: containment strategy, occupational exposure banding, and cleaning validation for cytotoxic payloads. Many conjugates now appear on the NIOSH hazardous drugs list, and handling expectations flow downstream to every site that touches the material.
  • Multi-site technology transfer: transfer packages, split responsibilities, and the governance model that keeps an antibody producer, a conjugation site, and a fill-finish partner aligned on one release specification.
  • Clinical pharmacology and bioanalytical strategy: aligning your analyte panel and assay plan with the FDA’s final guidance on antibody-drug conjugates, which covers bioanalytical methods, dosing strategy, exposure-response analysis, immunogenicity, and drug interaction assessment.
  • Supply chain resilience for linker-payload: dual sourcing, qualification timelines, and contingency planning for high-potency intermediates where the qualified supplier pool is genuinely small.

Our Areas of Expertise

DES Pharma delivers integrated support across biologics, advanced therapies, and small molecules, which is precisely the combination an ADC program requires:

  • Program & Process Development: development strategy from preclinical through commercial launch, designed for efficiency and product quality without over-engineering.
  • Quality Control & Analytics: method development, qualification, and validation aligned to global regulatory expectations at every phase.
  • Supply Chain & Procurement: sourcing and supply strategies built for reliability, scalability, and cost control.
  • Quality Assurance: deviation management, CAPA, batch release, and regulatory response preparation across multi-site networks.
  • Medical Safety & Pharmacovigilance: safety monitoring and risk management through the product lifecycle, including the payload-driven toxicities that shape ADC risk management plans.

Development strategy for conjugates also depends on a working command of the ICH quality guidelines, particularly where biologics and small molecule expectations overlap. If you want broader context on how outside technical partners fit into a development program, our pharma consulting guide is a useful starting point.

Attending World ADC San Diego 2026?
Let’s talk about your conjugate program while we are both in town.

Request a Meeting

Where Is World ADC San Diego 2026 Located?

The 17th World ADC San Diego will be held at the Town and Country Resort in Mission Valley, roughly ten minutes from San Diego International Airport.

  • Venue: Town and Country San Diego, 500 Hotel Circle North, San Diego, CA 92108, United States
  • Dates: October 12-15, 2026
  • Getting there: Mission Valley is served by the San Diego Trolley Green Line; the Fashion Valley and Hazard Center stops are both within walking distance of the resort.
  • Accommodation: Room blocks and travel details are listed on the venue and accommodation page.

Let’s Discuss Your ADC Program

Whether you are facing a tight IND timeline, a conjugation process that will not scale cleanly, an analytical package that keeps drawing questions, or a payload supply base with a single point of failure, our team is ready to help you move forward with confidence.

Meeting slots during World ADC San Diego 2026 fill quickly, so we recommend reaching out in advance. Request a meeting with the DES Pharma team and let us know which day works best for you.

About World ADC San Diego

World ADC San Diego is organized by Hanson Wade and is the longest-running conference series dedicated to antibody-drug conjugates and related bioconjugates. The program spans the full development chain, from discovery chemistry and biology through translational and clinical work to process development, manufacturing, and supply. Alongside the scientific sessions, the event features two all-day poster sessions, structured and informal networking blocks, and the World ADC Awards. Registration details are available at worldadc-usa.com.

Frequently Asked Questions About World ADC San Diego 2026

When and where is World ADC San Diego 2026?

The 17th World ADC San Diego runs October 12-15, 2026, at the Town and Country Resort, 500 Hotel Circle North, San Diego, CA 92108.

Who attends World ADC?

The audience spans oncology pharma, ADC-focused biotechs, early-stage companies, contract service providers, and academic and physician key opinion leaders. The organizers report more than 1,300 attendees from over 400 companies, with the majority at director level or above.

How is the four-day agenda structured?

The event opens with a pre-conference seminar day, followed by two main conference days running seven parallel tracks, and closes with a post-conference workshop day. A separate Introduction to ADCs day provides foundational content for teams newer to the modality.

What are the seven content tracks?

Discovery Chemistry, Discovery Biology, Preclinical, Translational Medicine, Clinical Lessons, Process & Analytical Development, and Manufacturing & Supply Chain.

Is there an exhibition hall?

Yes. The exhibition hall hosts service providers, poster sessions, and networking activity, including a new facilitated icebreaker session that groups attendees by area of ADC expertise.

How do I schedule time with DES Pharma during the event?

Use our contact form to request a meeting. Tell us your modality, current development stage, and the specific challenge you want to work through, and we will match you with the right person on our team before the event starts.

What should I bring to a technical meeting at World ADC?

A one-page program summary is usually enough: target and indication, antibody and payload class, current DAR and conjugation approach, stage of development, site map, and the two or three decisions you need to make in the next six months. That is plenty for a productive thirty-minute conversation, and it avoids spending half the meeting on background.

About DES Pharma (Dynamic Engineering Solutions)

DES Pharma is a global partner in drug development, providing integrated CMC, analytical, quality, and supply chain solutions to biotechnology and pharmaceutical companies. With a focus on speed, precision, and compliance, DES Pharma helps clients bring life-changing therapies to market efficiently and confidently. Learn more at despharmaconsulting.com.

Media Contact:
Diana Lee
Press Advisor
Diana@AsianInNY.com

Ready to connect?
If you are attending World ADC San Diego and want to talk through your CMC strategy, analytical development needs, or payload supply chain, we would like to meet.

Request a Meeting

Share

More Insights:

Connect With Our Team TodayAdvance Your Drug Program
with Confidence

Start building reliable, high-quality drug development programs today.